Stephen Moglia

Stephen Moglia has a diverse work experience spanning over several decades. Stephen is currently employed as the Senior Director of Finance at Neurelis, Inc, a position they have held since January 2020. Prior to this, Stephen worked at Nalpropion Pharmaceuticals, Inc. as the VP and Chief Accounting Officer from July 2018 to October 2019.

Stephen has also held notable positions at other companies such as Orexigen Therapeutics, where they were the VP and Chief Accounting Officer from February 2015 to July 2018, and the Senior Director of Financial Reporting and Controller from April 2008 to February 2015.

Before joining Orexigen Therapeutics, Stephen worked at Biosite as the Director of SEC Reporting and Compliance from May 2003 to August 2007. Prior to that, they served as the Controller at Alliance Pharmaceuticals from 1997 to 2003 and at The Burnham Institute from 1991 to 1997.

Stephen began their career at Ernst & Young, where they worked as a Senior Accountant from 1988 to 1991. Overall, Stephen Moglia has demonstrated a strong background in finance and accounting, with experience at various levels of leadership and across different industries.

Stephen Moglia received a Bachelor of Science degree in Accounting from San Diego State University. Stephen also holds an inactive CPA certification. The year of obtaining the degree and the status of the certification are not provided.